MIDAZOLAM, 1mg/ml, 5ml, amp
Valid Article
MIDAZOLAM
Therapeutic Action
Short-acting hypnotic and sedative with anxiolytic, anticonvulsant and muscle relaxant effect.
Derivative of the benzodiazepine group
Indications
Premedication, perioperative sedation, co-induction of general anaesthesia, sedation in intensive care.
First-line treatment for seizures in children, administered by buccal/intranasal route when IV access with diazepam is not possible.
- See: Perioperative management of surgical/trauma pain, MSF, 2024
- See: Standards for paediatric procedural sedation, MSF, 2021
- See: Neonatal care, Clinical and Therapeutic guidelines, MSF, 2021
- See: Paediatric care, Clinical and Therapeutic guidelines, MSF, 2024
- See: Essential drugs, MSF, 2024
- See: Local Anaesthetic Systemic Toxicity, MSF protocol, 2021
Instructions for use
For buccal/intranasal administration in children, it is recommended to use a mucosal atomization device.
Distribution to be controlled: narcotics register or supervision of amounts in and out, and storage under lock and key. (Cf Introduction: Narcotic and psychotropic medicines under international control).
Storage
Below 25ºC - Protect from sunlight